Valiant Laboratories Limited
Mainboard₹14,700 / Retail: 105 Shares
Valiant Laboratories Limited IPO Details
The Valiant Laboratories Limited IPO price band is set between ₹133-140 per equity share, with a face value of ₹10 per share. The issue is managed by Link Intime India Private Ltd, and the equity shares are proposed to be listed on the Mainboard.
The IPO date for subscription opens on 27 Sep, 2023 and closes on 3 Oct, 2023. Investors can check the allotment status on 4 Oct, 2023, while the listing date is tentatively scheduled for 6 Oct, 2023.
The total issue size is 11,556,000 shares , aggregating up to ₹152 Cr. Stay tuned for the latest Valiant Laboratories Limited IPO review and GMP updates.
Valiant Laboratories Limited IPO Review, Rating & Analysis
Valiant Laboratories Limited IPO Review
NO REVIEWValiant Laboratories Limited IPO Rating
Valiant Laboratories Limited IPO Highlights
IPO Date
Sep 27, 2023 - Oct 3, 2023
Listing Date
6 Oct, 2023
Face Value
₹10 Per Equity Share
Price Band
₹133-140 per equity share
Lot Size
-
Fresh Issue
Shares
Offer for Sale
-
Listing At
BSE, NSE
Valiant Laboratories Limited IPO Lot Size
The minimum market lot for Valiant Laboratories Limited IPO is 105 shares with an application amount of ₹14,700. Retail investors can apply for up to 13 lots. The table below details the minimum and maximum investment limits for Retail and HNI investors.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 105 | ₹14,700 |
| Retail (Max) | 13 | 1365 | ₹1,91,100 |
| S-HNI (Min) | 14 | 1470 | ₹2,05,800 |
| S-HNI (Max) | 68 | 7140 | ₹9,99,600 |
| B-HNI (Min) | 69 | 7245 | ₹10,14,300 |
Valiant Laboratories Limited IPO Timeline
Issue Price
₹133-140 per equity shareFace Value
₹10 Per Equity ShareListing at Group
BSE, NSERegistrar
Link Intime India Private LtdLead Manager
Unistone Capital Private LimitedIssue Size
11,556,000 shares (aggregating up to ₹152 Cr)#Fresh Issue: 11,556,000 shares (aggregating up to ₹152 Cr)Valiant Laboratories Limited IPO Financial Information
| Period Ended | Assets | Revenue | Profit After Tax | Net Worth | Reserves and Surplus | Total Borrowing |
|---|---|---|---|---|---|---|
| 31 Mar 23 | 212.76 | 338.77 | 29.00 | - | - | - |
| 31 Mar 22 | 181.81 | 293.47 | 27.50 | - | - | - |
| 31 Mar 21 | 106.31 | 183.78 | 30.59 | - | - | - |
All values are in ₹ Cr.
Promoters & Share Holding
Promoter(s) Name
- Shantilal Shivji Vora
- Dhanvallabh Ventures LLP (DVL)
| Share Holding Pre Issue | Share Holding Post Issue |
|---|---|
| 100% | 74.94% |
About Company
Valiant Laboratories Limited is a pharmaceutical ingredient manufacturing company in India having focuses on manufacturing Paracetamol.
The company's manufacturing unit is located in Palghar, Maharashtra, spread across 2,000 sq. mts. of land with an aggregate annual total installed capacity of 9,000 MT per annum. Valiant Laboratories also has an R&D Facility, equipped with an analytical laboratory and infrastructure for developmental activities in existing products.
For the Fiscal 2023, Fiscal 2022 and Fiscal 2021, Valiant Laboratories revenue from operations was Rs. 3,339.10 million, Rs. 2,915.23 million and Rs. 1,823.69 million, respectively.
Valiant Laboratories Limited imports Para Amino Phenol, being the raw material for the manufacture of Paracetamol from China and Cambodia.
As of April 30, 2023, Valiant Laboratories has 86 employees.
Valiant Laboratories Limited IPO Subscription Details
| As on | QIB | NII bNII sNII | Retail | Total |
|---|---|---|---|---|
| Shares Offered / Reserved | 2,178,030 | 1,633,500 1,088,999 544,501 | 3,811,500 | 7,623,030 |
Day 1 -27-09-23 05:00 PM | 0.00 x | 0.10 0.xx x 0.xx x | 0.62 x | 0.33 x |
Day 2 -28-09-23 05:00 PM | 0.05 x | 0.29 0.xx x 0.xx x | 1.29 x | 0.72 x |
Day 3 -29-09-23 05:00 PM | 1.04 x | 1.52 6.09 x 3.35 x | 3.14 x | 2.19 x |
Day 4 -03-10-23 05:00 PM | 20.83 x | 73.63 78.64 x 63.62 x | 16.05 x | 29.75 x |
Frequently Asked Questions about Valiant Laboratories Limited IPO
When will Valiant Laboratories Limited IPO open for subscription?
The Valiant Laboratories Limited IPO opens on 27 Sep, 2023 and closes on 3 Oct, 2023.
What is the investors portion for Valiant Laboratories Limited IPO?
The investors' portion for QIB is 20.83 x, NII is 78.64 x, and Retail is 16.05 x.
How to apply for Valiant Laboratories Limited IPO?
You can apply for Valiant Laboratories Limited IPO via ASBA online through your bank account. You can also apply via UPI through stock brokers like Zerodha, Upstox, or Paytm Money.
What is the issue size of Valiant Laboratories Limited IPO?
The issue size of Valiant Laboratories Limited IPO is approx ₹11,556,000 shares (aggregating up to ₹152 Cr)#Fresh Issue: 11,556,000 shares (aggregating up to ₹152 Cr) crores.
What is the price band of Valiant Laboratories Limited IPO?
The price band for Valiant Laboratories Limited IPO is ₹133 to ₹140 per equity share.
What is the lot size of Valiant Laboratories Limited IPO?
The minimum bid (lot size) for Valiant Laboratories Limited IPO is N/A shares with an investment of approx ₹14,700 .
What is the allotment date of Valiant Laboratories Limited IPO?
The allotment date for Valiant Laboratories Limited IPO is 4 Oct, 2023.
What is the listing date of Valiant Laboratories Limited IPO?
The listing date for Valiant Laboratories Limited IPO is expected to be 6 Oct, 2023.
What is the GMP of Valiant Laboratories Limited IPO?
The latest Grey Market Premium (GMP) for Valiant Laboratories Limited IPO is being updated regularly on IPOROCK.
Parth D.
Founder & Lead Analyst
Parth D. is a software engineer and financial analyst who brings a quantitative edge to IPO tracking. With deep expertise in algorithmic trading and financial tool development, he builds the technology that powers IPORock's real-time data engines. He has been tracking the Indian market since 2018.